Filter posts

Richard Pops: A Greater Patient Voice in Drug Development

In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward …

WSJ Editorial: The Medical Innovation Threat

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s …

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the …

Biotech Stocks: Perspective in a Bull Market

Investors are increasingly interested in biotechnology based on scientific breakthroughs, an improved regulatory environment, strong …

A Better Way to Make Unnatural Amino Acids Discovered by Yu

Certain amino acids that are not found in nature are highly sought after by pharmaceutical …

Making it Personal

The “valley of death” between drug discovery and the development and provision of therapy is …

Syringes for Clinical Trials

Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they …

Alliance Development Meets Animal Biotechnology

On June 3rd, 2014, BIO hosted a briefing entitled “The Untapped Potential of Advanced Modeling: …

Washington Post: Crowdsourcing Medical Decisions

On Monday, Ariana Eunjung Cha wrote about the difficult ethical issue of Compassionate Use, which allows a …

TRIPs Has Delivered: Patent Agreement Increases Drug Development

The TRIPs (Trade Related Aspects of Intellectual Property) Agreement, effective in 1996, has resulted in …